Page last updated: 2024-11-06

floxuridine and Duncan Disease

floxuridine has been researched along with Duncan Disease in 1 studies

Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
floxuridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.

Research Excerpts

ExcerptRelevanceReference
" Fragile sites expression induced by 5-fluorodeoxyuridine (FudR) or 5-bromodeoxyuridine (BrdU) was analyzed in 4 healthy individuals and 4 patients affected with lymphoproliferative disorders: one Hodgkin's disease, one mycosis fungoides and two chronic lymphoproliferative disorders."3.68[Expression of new fragile sites detected in lymphoproliferative processes]. ( Fundia, AF; Larripa, IB; Slavutsky, IR, 1990)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fundia, AF1
Slavutsky, IR1
Larripa, IB1

Other Studies

1 other study available for floxuridine and Duncan Disease

ArticleYear
[Expression of new fragile sites detected in lymphoproliferative processes].
    Sangre, 1990, Volume: 35, Issue:1

    Topics: Bromodeoxyuridine; Chromosome Fragile Sites; Chromosome Fragility; Chromosomes, Human; Floxuridine;

1990